142 related articles for article (PubMed ID: 19208825)
1. Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1).
Guo W; Wu S; Wang L; Wang RY; Wei X; Liu J; Fang B
Mol Cancer Ther; 2009 Feb; 8(2):441-8. PubMed ID: 19208825
[TBL] [Abstract][Full Text] [Related]
2. Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota.
Guo W; Wu S; Liu J; Fang B
Cancer Res; 2008 Sep; 68(18):7403-8. PubMed ID: 18794128
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition.
Guo W; Wu S; Wang L; Wei X; Liu X; Wang J; Lu Z; Hollingshead M; Fang B
PLoS One; 2011; 6(12):e28487. PubMed ID: 22174819
[TBL] [Abstract][Full Text] [Related]
4. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
Dow EC; Liu H; Rice AP
J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
[TBL] [Abstract][Full Text] [Related]
5. Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.
Wu S; Wang L; Guo W; Liu X; Liu J; Wei X; Fang B
J Med Chem; 2011 Apr; 54(8):2668-79. PubMed ID: 21443218
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II.
Cabart P; Chew HK; Murphy S
Oncogene; 2004 Jul; 23(31):5316-29. PubMed ID: 15107825
[TBL] [Abstract][Full Text] [Related]
7. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells.
Stallings-Mann M; Jamieson L; Regala RP; Weems C; Murray NR; Fields AP
Cancer Res; 2006 Feb; 66(3):1767-74. PubMed ID: 16452237
[TBL] [Abstract][Full Text] [Related]
8. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.
Gupta P; Dixit D; Sen E
Carcinogenesis; 2013 Feb; 34(2):388-96. PubMed ID: 23125226
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo.
Murray NR; Jamieson L; Yu W; Zhang J; Gökmen-Polar Y; Sier D; Anastasiadis P; Gatalica Z; Thompson EA; Fields AP
J Cell Biol; 2004 Mar; 164(6):797-802. PubMed ID: 15024028
[TBL] [Abstract][Full Text] [Related]
10. RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes.
Nowak DE; Tian B; Jamaluddin M; Boldogh I; Vergara LA; Choudhary S; Brasier AR
Mol Cell Biol; 2008 Jun; 28(11):3623-38. PubMed ID: 18362169
[TBL] [Abstract][Full Text] [Related]
11. Interactions between the aryl hydrocarbon receptor and P-TEFb. Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter.
Tian Y; Ke S; Chen M; Sheng T
J Biol Chem; 2003 Nov; 278(45):44041-8. PubMed ID: 12917420
[TBL] [Abstract][Full Text] [Related]
12. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
13. Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids.
Linch M; Sanz-Garcia M; Rosse C; Riou P; Peel N; Madsen CD; Sahai E; Downward J; Khwaja A; Dillon C; Roffey J; Cameron AJ; Parker PJ
Carcinogenesis; 2014 Feb; 35(2):396-406. PubMed ID: 24072773
[TBL] [Abstract][Full Text] [Related]
14. Rab2 interacts directly with atypical protein kinase C (aPKC) iota/lambda and inhibits aPKCiota/lambda-dependent glyceraldehyde-3-phosphate dehydrogenase phosphorylation.
Tisdale EJ
J Biol Chem; 2003 Dec; 278(52):52524-30. PubMed ID: 14570876
[TBL] [Abstract][Full Text] [Related]
15. Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase.
Jin Z; Xin M; Deng X
J Biol Chem; 2005 Apr; 280(16):16045-52. PubMed ID: 15705582
[TBL] [Abstract][Full Text] [Related]
16. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
[TBL] [Abstract][Full Text] [Related]
17. RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo.
Misteli T; Spector DL
Mol Cell; 1999 Jun; 3(6):697-705. PubMed ID: 10394358
[TBL] [Abstract][Full Text] [Related]
18. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
[TBL] [Abstract][Full Text] [Related]
19. Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 site in the PKCiota promoter.
Gustafson WC; Ray S; Jamieson L; Thompson EA; Brasier AR; Fields AP
J Biol Chem; 2004 Mar; 279(10):9400-8. PubMed ID: 14670960
[TBL] [Abstract][Full Text] [Related]
20. Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages.
Liou LY; Haaland RE; Herrmann CH; Rice AP
J Leukoc Biol; 2006 Feb; 79(2):388-96. PubMed ID: 16330531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
